The difference in prevalence of sarcopenia in cancer patients based on different cut-off values

Van Den Broeck, J. (Speaker), Martine Sealy (Contributor), Brussaard, C. (Contributor), Harriët Jager-Wittenaar (Contributor), Scafoglieri, A. (Contributor)

Activity: Talk or presentationTalk or presentation at a conference


Based on the different cut-off values to diagnose sarcopenia, the prevalence in cancer patients is very different. The cut-off values, calculated based on twice the standard deviation and associated with lower survival, achieve lower scores for the prevalence of sarcopenia. While cut-off values, based on the median of the sample and based on the cut-off values used for dual energy X-ray absorptiometry (DXA), achieve higher scores for the prevalence.
It is important to consider that the difference in diagnosis of sarcopenia is determinative for the therapy for this cancer patients. Therefore the chosen cut-off values play an important role in this diagnosis.
Period13 Dec 2020
Event title13the international fully digital conference on cachexia, sarcopenia and muscle wasting: SCWD digital experience
Event typeConference
Conference number13